IMCAS Academy

Introduction
Program
Speakers
Sponsor list
Accreditation

IMCAS World Congress 2018
Program

FOCUS ON S271, S272

R&D

Room: Room 10
Date: Saturday 3 February 2018 at 16:30 to 18:30
Format: FOCUS SESSION > lectures covering a major topic of the congress

Chairs

Prof Serge MORDON

PhD - Research

France

Prof Neil S SADICK

Dermatologist

United States

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
16:30	Prof Neil S SADICK	Whole body rejuvenation	View	63661
16:40	Dr Corey S MAAS	Duration as a measure of efficacy in botulinum toxins: a double-blind controlled safety trial employing incobotulinum toxin type A		65517
16:50	Prof Gary D MONHEIT	Duration of Effect in Two Phase 3, Randomized, Double-Blind, Placebo Controlled, Multi-Center Trials Evaluating Safety & Efficacy of DaxibotulinumtoxinA for Injection Treating Moderate to Severe Glabellar Lines (SAKURA 1 & 2)	View	65515
17:00	Prof Andy PICKETT	Botulinum toxin 2017: myths and realities		59809
17:10	Dr Natalia VOLKOVA	A new microablative method of acousic-inteference microinjury of the tissues as a unique concept of laser technology: the five year practice experience and long-term results: rejuvenation, scars and stretch marks	View	55569
17:20	Dr Richard D GENTILE	Helium activated cold plasma for skin and soft tissue rejuvenation	View	57875
17:30	Prof David J GOLDBERG	Novel silicone dressings for scar prevention		59959
17:40	Prof Barry DIBERNARDO	Open-label, single-center, single-treatment, safety and effectiveness evaluation of percutaneous radiofrequency	View	60065
17:50	Romain ROYON	Start up: picosecond laser	View	58087
18:00	Dr Christine DIERICKX	Long term hair removal with microwave energy		60189

Go to previous session

Go to next room (Room 11)

Recommended sessions

R & D

Energy-based devices (EBD)

Lasers

Scars

Hair removal

Prof Neil S SADICK

Dermatologist

United States

Other author(s) :

Whole body rejuvenation

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Corey S MAAS

Facial Plastic Surgeon

United States

Other author(s) :

Duration as a measure of efficacy in botulinum toxins: a double-blind controlled safety trial employing incobotulinum toxin type A

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: Our Research was supported, in advance, by an advance unrestricted Research grant by Merz Inc.

Prof Gary D MONHEIT

Dermatologist

United States

Other author(s) : Gary Monheit, MD,1 Joely Kaufman-Janette, MD,2 Vince Bertucci, MD,3 Steve Fagien, MD,4 Eric Park, MD,5 Daniel Snyder, PhD,5* and Roman G. Rubio, MD5

Duration of Effect in Two Phase 3, Randomized, Double-Blind, Placebo Controlled, Multi-Center Trials Evaluating Safety & Efficacy of DaxibotulinumtoxinA for Injection Treating Moderate to Severe Glabellar Lines (SAKURA 1 & 2)

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): Revance Therapeutics, Inc.

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): Revance Therapeutics, Inc.

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): Allergan, plc, Ipsen

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: Revance Therapeutics, Inc.

Prof Andy PICKETT

PhD - Research

United Kingdom

Other author(s) :

Botulinum toxin 2017: myths and realities

Dr Natalia VOLKOVA

Dermatologist

Russia

Other author(s) :

A new microablative method of acousic-inteference microinjury of the tissues as a unique concept of laser technology: the five year practice experience and long-term results: rejuvenation, scars and stretch marks

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Richard D GENTILE

Plastic Surgeon

United States

Other author(s) :

Helium activated cold plasma for skin and soft tissue rejuvenation

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Prof David J GOLDBERG

Dermatologist

United States

Other author(s) :

Novel silicone dressings for scar prevention

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Prof Barry DIBERNARDO

Plastic Surgeon

United States

Other author(s) :

Open-label, single-center, single-treatment, safety and effectiveness evaluation of percutaneous radiofrequency

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): THERMI

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): THERMI

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: THERMI

Romain ROYON

Industry Representative

France

Other author(s) :

Start up: picosecond laser

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
Yes
Please specify date...: Applied
and status : 2016

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Christine DIERICKX

Dermatologist

Luxembourg

Other author(s) :

Long term hair removal with microwave energy

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Americas
IMCAS Asia
IMCAS World Congress

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS World Congress 2018 Program

FOCUS ON S271, S272

R&D

Chairs

Lectures of the session

Recommended sessions

IMCAS World Congress 2018
Program